The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Tiapride-Global Market Insights and Sales Trends 2024
Synopsis
Tiapride is a compound that selectively blocks D2 and D3 dopamine receptors in the brain. It is often used to treat a variety of neurological and psychiatric disorders.
The global Tiapride market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Tiapride in various end use industries. The expanding demands from the Alcoholism, Agitation and Aggression and Movement Disorders,, are propelling Tiapride market. Powder, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Liquid segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Tiapride market, driven by demand from China, the second largest economy with some signs of stabilising, the Tiapride market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tiapride, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tiapride market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tiapride market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tiapride sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tiapride covered in this report include Toronto Research Chemical, ChemScence, JSN Chemical, Century Pharmaceuticals, Henan Tianfu Chemical, Huvepharma Italia Srl, Bettering Biotech, Lebsa and Sanofi, etc.
The global Tiapride market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Toronto Research Chemical
ChemScence
JSN Chemical
Century Pharmaceuticals
Henan Tianfu Chemical
Huvepharma Italia Srl
Bettering Biotech
Lebsa
Sanofi
Daito
Finorga SA
Huvepharma
ICROM
Global Tiapride market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tiapride market, Segment by Type:
Powder
Liquid
Other
Global Tiapride market, by Application
Alcoholism
Agitation and Aggression
Movement Disorders
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Tiapride manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Tiapride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Tiapride is a compound that selectively blocks D2 and D3 dopamine receptors in the brain. It is often used to treat a variety of neurological and psychiatric disorders.
The global Tiapride market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Tiapride in various end use industries. The expanding demands from the Alcoholism, Agitation and Aggression and Movement Disorders,, are propelling Tiapride market. Powder, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Liquid segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Tiapride market, driven by demand from China, the second largest economy with some signs of stabilising, the Tiapride market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tiapride, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tiapride market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tiapride market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tiapride sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tiapride covered in this report include Toronto Research Chemical, ChemScence, JSN Chemical, Century Pharmaceuticals, Henan Tianfu Chemical, Huvepharma Italia Srl, Bettering Biotech, Lebsa and Sanofi, etc.
The global Tiapride market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Toronto Research Chemical
ChemScence
JSN Chemical
Century Pharmaceuticals
Henan Tianfu Chemical
Huvepharma Italia Srl
Bettering Biotech
Lebsa
Sanofi
Daito
Finorga SA
Huvepharma
ICROM
Global Tiapride market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tiapride market, Segment by Type:
Powder
Liquid
Other
Global Tiapride market, by Application
Alcoholism
Agitation and Aggression
Movement Disorders
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Tiapride manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Tiapride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Tiapride Market Overview
1.1 Tiapride Product Overview
1.2 Tiapride Market Segment by Type
1.2.1 Powder
1.2.2 Liquid
1.2.3 Other
1.3 Global Tiapride Market Size by Type
1.3.1 Global Tiapride Market Size Overview by Type (2018-2029)
1.3.2 Global Tiapride Historic Market Size Review by Type (2018-2023)
1.3.3 Global Tiapride Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Tiapride Sales Breakdown by Type (2018-2023)
1.4.2 Europe Tiapride Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Tiapride Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Tiapride Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Tiapride Sales Breakdown by Type (2018-2023)
2 Global Tiapride Market Competition by Company
2.1 Global Top Players by Tiapride Sales (2018-2023)
2.2 Global Top Players by Tiapride Revenue (2018-2023)
2.3 Global Top Players by Tiapride Price (2018-2023)
2.4 Global Top Manufacturers Tiapride Manufacturing Base Distribution, Sales Area, Product Type
2.5 Tiapride Market Competitive Situation and Trends
2.5.1 Tiapride Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Tiapride Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tiapride as of 2022)
2.7 Date of Key Manufacturers Enter into Tiapride Market
2.8 Key Manufacturers Tiapride Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Tiapride Status and Outlook by Region
3.1 Global Tiapride Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Tiapride Historic Market Size by Region
3.2.1 Global Tiapride Sales in Volume by Region (2018-2023)
3.2.2 Global Tiapride Sales in Value by Region (2018-2023)
3.2.3 Global Tiapride Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Tiapride Forecasted Market Size by Region
3.3.1 Global Tiapride Sales in Volume by Region (2024-2029)
3.3.2 Global Tiapride Sales in Value by Region (2024-2029)
3.3.3 Global Tiapride Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Tiapride by Application
4.1 Tiapride Market Segment by Application
4.1.1 Alcoholism
4.1.2 Agitation and Aggression
4.1.3 Movement Disorders
4.2 Global Tiapride Market Size by Application
4.2.1 Global Tiapride Market Size Overview by Application (2018-2029)
4.2.2 Global Tiapride Historic Market Size Review by Application (2018-2023)
4.2.3 Global Tiapride Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Tiapride Sales Breakdown by Application (2018-2023)
4.3.2 Europe Tiapride Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Tiapride Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Tiapride Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Tiapride Sales Breakdown by Application (2018-2023)
5 North America Tiapride by Country
5.1 North America Tiapride Historic Market Size by Country
5.1.1 North America Tiapride Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Tiapride Sales in Volume by Country (2018-2023)
5.1.3 North America Tiapride Sales in Value by Country (2018-2023)
5.2 North America Tiapride Forecasted Market Size by Country
5.2.1 North America Tiapride Sales in Volume by Country (2024-2029)
5.2.2 North America Tiapride Sales in Value by Country (2024-2029)
6 Europe Tiapride by Country
6.1 Europe Tiapride Historic Market Size by Country
6.1.1 Europe Tiapride Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Tiapride Sales in Volume by Country (2018-2023)
6.1.3 Europe Tiapride Sales in Value by Country (2018-2023)
6.2 Europe Tiapride Forecasted Market Size by Country
6.2.1 Europe Tiapride Sales in Volume by Country (2024-2029)
6.2.2 Europe Tiapride Sales in Value by Country (2024-2029)
7 Asia-Pacific Tiapride by Region
7.1 Asia-Pacific Tiapride Historic Market Size by Region
7.1.1 Asia-Pacific Tiapride Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Tiapride Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Tiapride Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Tiapride Forecasted Market Size by Region
7.2.1 Asia-Pacific Tiapride Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Tiapride Sales in Value by Region (2024-2029)
8 Latin America Tiapride by Country
8.1 Latin America Tiapride Historic Market Size by Country
8.1.1 Latin America Tiapride Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Tiapride Sales in Volume by Country (2018-2023)
8.1.3 Latin America Tiapride Sales in Value by Country (2018-2023)
8.2 Latin America Tiapride Forecasted Market Size by Country
8.2.1 Latin America Tiapride Sales in Volume by Country (2024-2029)
8.2.2 Latin America Tiapride Sales in Value by Country (2024-2029)
9 Middle East and Africa Tiapride by Country
9.1 Middle East and Africa Tiapride Historic Market Size by Country
9.1.1 Middle East and Africa Tiapride Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Tiapride Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Tiapride Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Tiapride Forecasted Market Size by Country
9.2.1 Middle East and Africa Tiapride Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Tiapride Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Toronto Research Chemical
10.1.1 Toronto Research Chemical Company Information
10.1.2 Toronto Research Chemical Introduction and Business Overview
10.1.3 Toronto Research Chemical Tiapride Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Toronto Research Chemical Tiapride Products Offered
10.1.5 Toronto Research Chemical Recent Development
10.2 ChemScence
10.2.1 ChemScence Company Information
10.2.2 ChemScence Introduction and Business Overview
10.2.3 ChemScence Tiapride Sales, Revenue and Gross Margin (2018-2023)
10.2.4 ChemScence Tiapride Products Offered
10.2.5 ChemScence Recent Development
10.3 JSN Chemical
10.3.1 JSN Chemical Company Information
10.3.2 JSN Chemical Introduction and Business Overview
10.3.3 JSN Chemical Tiapride Sales, Revenue and Gross Margin (2018-2023)
10.3.4 JSN Chemical Tiapride Products Offered
10.3.5 JSN Chemical Recent Development
10.4 Century Pharmaceuticals
10.4.1 Century Pharmaceuticals Company Information
10.4.2 Century Pharmaceuticals Introduction and Business Overview
10.4.3 Century Pharmaceuticals Tiapride Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Century Pharmaceuticals Tiapride Products Offered
10.4.5 Century Pharmaceuticals Recent Development
10.5 Henan Tianfu Chemical
10.5.1 Henan Tianfu Chemical Company Information
10.5.2 Henan Tianfu Chemical Introduction and Business Overview
10.5.3 Henan Tianfu Chemical Tiapride Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Henan Tianfu Chemical Tiapride Products Offered
10.5.5 Henan Tianfu Chemical Recent Development
10.6 Huvepharma Italia Srl
10.6.1 Huvepharma Italia Srl Company Information
10.6.2 Huvepharma Italia Srl Introduction and Business Overview
10.6.3 Huvepharma Italia Srl Tiapride Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Huvepharma Italia Srl Tiapride Products Offered
10.6.5 Huvepharma Italia Srl Recent Development
10.7 Bettering Biotech
10.7.1 Bettering Biotech Company Information
10.7.2 Bettering Biotech Introduction and Business Overview
10.7.3 Bettering Biotech Tiapride Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Bettering Biotech Tiapride Products Offered
10.7.5 Bettering Biotech Recent Development
10.8 Lebsa
10.8.1 Lebsa Company Information
10.8.2 Lebsa Introduction and Business Overview
10.8.3 Lebsa Tiapride Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Lebsa Tiapride Products Offered
10.8.5 Lebsa Recent Development
10.9 Sanofi
10.9.1 Sanofi Company Information
10.9.2 Sanofi Introduction and Business Overview
10.9.3 Sanofi Tiapride Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Sanofi Tiapride Products Offered
10.9.5 Sanofi Recent Development
10.10 Daito
10.10.1 Daito Company Information
10.10.2 Daito Introduction and Business Overview
10.10.3 Daito Tiapride Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Daito Tiapride Products Offered
10.10.5 Daito Recent Development
10.11 Finorga SA
10.11.1 Finorga SA Company Information
10.11.2 Finorga SA Introduction and Business Overview
10.11.3 Finorga SA Tiapride Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Finorga SA Tiapride Products Offered
10.11.5 Finorga SA Recent Development
10.12 Huvepharma
10.12.1 Huvepharma Company Information
10.12.2 Huvepharma Introduction and Business Overview
10.12.3 Huvepharma Tiapride Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Huvepharma Tiapride Products Offered
10.12.5 Huvepharma Recent Development
10.13 ICROM
10.13.1 ICROM Company Information
10.13.2 ICROM Introduction and Business Overview
10.13.3 ICROM Tiapride Sales, Revenue and Gross Margin (2018-2023)
10.13.4 ICROM Tiapride Products Offered
10.13.5 ICROM Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Tiapride Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Tiapride Industrial Chain Analysis
11.4 Tiapride Market Dynamics
11.4.1 Tiapride Industry Trends
11.4.2 Tiapride Market Drivers
11.4.3 Tiapride Market Challenges
11.4.4 Tiapride Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Tiapride Distributors
12.3 Tiapride Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
